(Reuters) – U.S. drugmaker Amgen said on Thursday it will invest $1 billion towards a second drug substance manufacturing facility in North Carolina.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Tasim Zahid)
(Reuters) – U.S. drugmaker Amgen said on Thursday it will invest $1 billion towards a second drug substance manufacturing facility in North Carolina.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Tasim Zahid)

Comments